top of page
shutterstock_631636766_edited.jpg

Multiple cancer detection.
Lifesaving innovation.
One easy test.

Want yours?

Understand Multi-Cancer Early Detection Blood Test

Non-invasive

A standard blood draw that clinics and labs can do

Wider cancer coverage

A shared signal cross multiple cancers

Accurate

Miss fewer cancer cases in early stages and very low false positives

Science behind miRoncol's Test

How to Get the Test

While miRoncol's test is still under development. We plan to launch pilot tests in Canada when it is ready.

​

Current proof of concept study (in silico study)  is based on public datasets of 11,000+ blood samples with their miRNA expression level data covering 12+ cancer types.

 

miRoncol’s novel diagnostics model generated from machine learning demonstrated superior performance in term of accuracy.

 

The latest publication of the improved model is available at scientific reports, a prestigious journal under nature. 

I want to TAKE the blood test

miRoncol offers a fully refundable eventbrite ticket to our planned announcement at February 4, 2027 to guarantee a capped price of $299 for our test once its launched with an estimated value of $100+. The ticket price is $99 and be either fully refunded or converted to payment of the test.

You will need a doctor to prescribe the test for you. At the time of mironcol’s launch event, you will be notified how to get your prescription from a doctor in mironcol’s partner network.

All purchaser will have the opportunity to win a free book of the New York Best Seller "Outlive: the Science & Art of Longevity", by Dr. Peter Attia, value at CA$42.00.

 

Make sure to leave your email so that you can get the details of how the book can be delivered to you. If you won the free gift, you can choose what format of the book is preferred, hardcopy, digital or audio. 

miRoncol 400dpiLogoCroppedNewColor
miRoncol ™

A miracle in oncology made possible with miRNA

1000 Innovation Dr., 5F

Ottawa, ON K2K 3E7, Canada

​

DISCLAIMER

This website may contain certain statements, estimations, projections, assessments and other information with respect to the anticipated future performance of the Company and/or its market and involve risks and uncertainties. Actual results or future business decisions of the Company may differ materially from any expectations, projections or predictions made or implicated in statements made in this website. While the Company believes that the information contained herein is accurate, it expressly disclaims any and all liability for representations or warranties, expressed or implied, contained in, or for omissions from, this website or any other communication transmitted or made available herein. Any prospective website user acknowledges his/her responsibility to perform a due diligence review prior to consummating a transaction with the Company. Included in this website are certain declarations by the Company with respect to its anticipated future performance. These declarations are based on estimates and assumptions by the Company that are subject to economic and competitive uncertainties beyond the control of the Company. The Company does not provide representation or warranty with regard to the declarations and there can be no assurance that the future results will be realized or that actual results will not be significantly different from those projected. The Company is not obligated to update or revise any future declarations. The Company and its respective affiliates, directors, officers, employees, consultants and representatives expressly disclaim any and all liability relating to or resulting from the utilization of any information contented in this website. The Company does not have any obligation to provide with access to additional information.

© 2021 - 2025 by miRoncol ™. All rights reserved.

bottom of page